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Subnormal Heart Period Variability in Heart Failure   Effect of
Cardiac Transplantation
MICHAEL L. SMITH, PHD, KENNETH A . ELLENBOGEN, MD, FACC,
DWAIN L . ECKBERG, MD, SZABOLCS SZENTPETERY, MD, MARC D. THAMES, MD, FACC
Richmond, Virginia
Heart period variability and arterial baroreceptor-cardiac
reflex function were studied in cardiac transplant patients
to determine if correction of heart failure restores parasym-
pathetic control mechanisms toward normal . Heart period
variability (standard deviation [SDI of 120 consecutive RR
or PP intervals) was measured at supine rest in 34 patients
with congestive heart failure (23 patients receiving diuret-
ics, digoxin or vasodilators and 11 patients weaned from all
medications), 30 cardiac transplant patients (both inner-
vated recipient and denervated donor atrial rates) and 16
age-matched healthy control subjects . Arterial baroreflex
gain was evaluated with intravenous bolus injections of
phenylephrine in 22 transplant patients .
Mean heart period variability (± SEM) was significantly
lower (p < 0 .05) in the heart failure groups (22 ± 3 ms for
medicated and 17 ± 3 ms for nonmedicated) than in the
transplant patients (41 ± 5 ms) or control subjects (58 ± 5
Several investigations (1-5) have demonstrated decreased
baseline vagal activity and arterial baroreflex gain in conges-
tive heart failure in animals and humans . Cardiac transplan-
tation corrects the abnormal hemodynamic and cardiac
function and subnormal baroreflex gain of congestive heart
failure (6) . However, the effect of cardiac transplantation on
baseline parasympathetic activity has not been investigated .
Parasympathetic control of the heart can be assessed both
from the baseline level of vagal efferent nerve traffic and
from the vagal efferent nerve traffic response to baroreceptor
stimulation . These two measures provide different informa-
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ms). Heart period variability of the transplant patients was
less than that of the control patients (p < 0 .05) . A stepwise
regression model revealed that heart period variability was
inversely related to systolic arterial pressure and directly
related to time after transplantation (R 2 = 0.3  ; p = 0.03)
in the transplant patients . Baroreflex gain of normotensive
transplant patients was normal (11 .7 ± 1 .0 ms/mm Hg) and
correlated directly with heart period variability (r = 0 .62 ;
p < 0 .001) .
These data suggest that subnormal levels of cardiac
parasympathetic activity at rest associated with congestive
heart failure can be restored progressively toward normal
by correction of congestive heart failure after cardiac
transplantation . Post-transplant hypertension opposes this
correction of baseline parasympathetic activity .
(J Am Coll Cardiol 1 8 
;14
 106-11)
tion about parasympathetic efferent activity . Our group (6)
recently reported that after cardiac transplantation and re-
versal of congestive heart failure, arterial baroreflex gain
returns to normal . These data suggest that baroreflex-
mediated parasympathetic responses are normal in trans-
plant patients. However, these data provide no insight into
the extent to which baseline parasympathetic activity also
returns toward normal .
Baseline cardiac-vagal nerve activity has not been mea-
sured directly in humans, but can be estimated from the
heart period variability associated with respiration (7) . Heart
period variability is reduced in patients with chronic conges-
tive heart failure (4) . Relatively little is known about the
reversibility of this abnormality when heart failure is cor-
rected and cardiac function is normalized by cardiac trans-
plantation .
The technique of orthotopic cardiac transplantation
leaves portions of the recipient atria intact . The recipient
atria) remnant and sinus node remain innervated after trans-
plantation, thereby allowing assessment of heart period
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JACC Vol . 14, No . I
July 1 8   106-lI
variability and arterial baroreflex parasympathetic influence
on the recipient sinus node . We attempted to determine if the
subnormal baseline parasympathetic influence on the heart
associated with low output congestive failure returns toward
normal after orthotopic cardiac transplantation by employ-
ing a cross-sectional comparison of heart period variability
in patients with chronic heart failure, cardiac transplant
patients and age-matched control subjects .
Methods
Study subjects . Studies were performed in 7  male vol-
unteers (age 31 to 68 years ; mean ± SEM = 45 ± 2 years)
who gave written informed consent . The study was ap-
proved by the Medical College of Virginia Committee on the
Conduct of Human Research . Thirty patients were studied at
periods ranging from 2 weeks to 5 years after orthotopic
cardiac transplantation (mean = 28 ± 10 weeks). Twenty-
three patients with severe congestive heart failure (New
York Heart Association class III-IV) were studied while
receiving medications (including diuretics, digoxin, an-
giotensin-converting enzyme inhibitors and calcium channel
blockers), and 11 patients with severe congestive heart
failure (class III-IV) were studied after all medications were
stopped for four or more half-lives . Sixteen healthy age-
matched subjects free of organic heart disease were studied
as a control group .
Measurements of heart period variability . All studies
were performed with subjects in the postprandial state .
Patients were excluded from this study if ventricular or atrial
premature beats occurred at a rate >4 beats/min . A standard
electrocardiographic (ECG) limb lead rhythm strip was
obtained in all patients with congestive heart failure and
control subjects ; an esophageal ECG lead or intracavitary
electrogram, with donor and recipient atrial activity dis-
played on separate channels, was obtained from the trans-
plant patients . Subjects were asked to breathe in a relaxed
constant manner. After 20 min of supine rest, an ECG
rhythm strip was obtained for determination of mean RR
interval and heart period variability . Rhythm strips were
obtained from a strip chart recorder (Electronics for Medi-
cine, VR-16) at a paper speed of 100 mm/s (accuracy of ±5
ms) .
Heart period variability was characterized as the (SD) of
120 consecutive sinus rhythm RR intervals with a calibrated
digitizing tablet (SigmaScan, Jandel Scientific) . To deter-
mine whether 120 RR intervals were adequate to obtain an
accurate assessment of heart period variability, measure-
ments were made over 5 min in four subjects . We found
these two estimates to be in close agreement (<4% differ-
ence) with measurements made over 120 heartbeats . All
measurements were made by a single observer to avoid
interobserver variability .
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Table 1 . Therapy Summary of Patient Groups
*Values represent number of patients receiving each treatment at the time
of study . ACE = angiotensin-converting enzyme . Eleven additional heart
failure patients had been weaned from all medications .
Arterial baroreflex control of the sinus node . This variable
was evaluated from the PP interval responses to a bolus
injection of phenylephrine in 22 transplant patients with a
systolic arterial pressure <160 mm Hg . Arterial pressure
was measured continuously with a 7F sheath in the femoral
artery connected to a pressure transducer . Arterial pressure
and RR interval were monitored while a bolus of phenyleph-
rine was injected intravenously over 5 to 10 s . An initial dose
of 50 µg was given and subsequent doses were given until
arterial pressure was increased by at least 20 mm Hg . Each
systolic pressure was correlated with the following PP inter-
val, and least squares linear regression analyses were per-
formed . The slope of each PP interval-systolic pressure
relation was determined .
Statistics . Group comparisons were performed with a
general linear model one-way analysis of variance . A Stu-
dent-Neuman-Keuls post-hoc analysis was used to distin-
guish main effect differences among groups . A probability of
p < 0.05 was considered significant . A forward-selection
stepwise regression analysis, with a model entry significance
level of 0 .25, was used to develop a model of pretransplant
and post-transplant clinical characteristics for the prediction
of heart period variability in the transplant patients (8) .
Variables tested for the model included   duration of class IV
heart failure, pretransplant ejection fraction, post-transplant
systolic and diastolic arterial pressures, time after transplan-
tation, post-transplant ejection fraction and age . The model
R2 value represents the percentage of the variation of the
data explained by the model . The model R 2 is used to
describe the statistical findings because it provides more
succinct information about the model than do the partial
correlation coefficients .
Results
Patient characteristics. Table I summarizes the general
characteristics of the patient groups . All but two transplant
patients were receiving both cyclosporine and azathioprine
Transplant
Group
(n = 30)
Heart Failure
Group*
(n = 23)
Cyclosporine 28
Imuran 2 
Prednisone 14
Beta-blocker 5
Diuretics 22 21
Calcium channel blocker 2 13
Digoxin 16
ACE inhibitor 2 14
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Table 2. Summary of Post-Hoc Analysis of Group Comparisons
*Significant difference from all other groups   tsignificant difference from
transplant donor only ; $significant difference from all except nonmedicated
heart failure (p < 0 .05) . All values are mean ± SEM .
as immunosuppressive therapy . Prednisone and diuretics
also were common components of therapy . All patients with
heart failure were receiving combination therapy that in-
cluded digoxin, a diuretic, an angiotensin-converting en-
zyme inhibitor and a calcium channel blocker .
Baseline RR intervals at rest (Table 2). Individual and
mean data for all groups are summarized in Figures I and 2 .
Baseline RR interval ( 84 ± 3  ms) and heart period vari-
ability (58 ± 5 ms) were significantly greater in the control
subjects than in the other groups studied . Baseline RR
interval was not significantly different among the two heart
failure groups (820 ± 27 ms for the medicated group, and 725
44 ms for the nonmedicated group) and the transplant
recipient atrium (PP interval  810 ± 31 ms). However,
average RR intervals in the transplant donor (denervated)
hearts (683 ± 26 ms) were significantly lower than were
those in the transplant recipient (innervated) atria or in the
patients with heart failure receiving medication (p < 0 .05) .
Figure 1 . Baseline RR interval measured during quiet rest in 16
healthy control subjects (C), 23 medicated patients with heart failure
(HFm ), I1 nonmedicated patients with heart failure (HF n ), 21 donor
atria of orthotopic cardiac transplant patients (T d ) and 30 recipient
atria of orthotopic cardiac transplant patients (Tr ) . Each open circle
represents an individual subject, whereas the solid circles and
brackets represent the group means ± SEM . See Table 2 for
statistical comparisons of group means .
HF HF T
m n r
Subject Group
HF HF
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Subject Group
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Figure 2. Heart period variability measured during quiet rest in 16
healthy control subjects (C), 23 medicated patients with heart failure
(HFm ), I I nonmedicated patients with heart failure (HF.), 21 donor
atria of orthotopic cardiac transplant patients (T d ) and 30 recipient
atria of orthotopic cardiac transplant patients (Td . Each open circle
represents an individual subject, whereas the solid circles and
brackets represent the group means ± SEM . See Table 2 for
statistical comparisons of group means .
Heart period variability (Table 2). Mean heart period
variability was diverse among groups with the groups aligned
in the following ascending order   transplant donor heart
lower than heart failure with no medication lower than heart
failure with medication lower than transplant recipient heart
lower than normal (Fig . 2) . Heart period variability in the
control group was significantly greater than that in all other
groups . Heart period variability in the transplant recipient
atria was less than that in the control group, but greater than
that in all other groups . Heart period variability in the
nonmedicated patients with heart failure was not signifi-
cantly different from that in the medicated patients with
heart failure or the transplant donor hearts ; however, heart
period variability in the medicated patients with heart failure
was greater than that in the transplant donor hearts .
The distribution ofheart period variability for each group
is illustrated in Figure 2 . The distribution of the transplant
recipient heart period variability and baseline PP interval
data was broad, spanning a range from severely abnormal
(10 to 15 ms) to normal (>50 ms) levels . Stepwise regression
and correlation analyses were performed to discern common
determinants of normal and abnormal heart period variabil-
ity in these transplant patients . The correlation between
heart period variability and baseline PP interval in the
recipient transplant atria was significant (r = 0.65, p <
0.0001) (Fig . 3) .
Factors affecting heart period variability . Stepwise re-
gression analysis produced a model of clinical variables that
indicated the best predictors of heart period variability after
transplantation . Only two variables met the entry criterion  
systolic arterial pressure and time after transplantation . The
model was moderately significant as a predictor of heart
Group
RR Interval
at Rest
(ms)
Heart Period
Variability
(ms)
Control (n = 16)  84 ± 3 * 58 ± 5*
Transplant, recipient (n = 30) 810 ± 31t 41 ± 5*
Heart failure, medicated (n = 23) 820 ± 27t 22 ± 3t
Heart failure, nonmedicated (n = 11) 725 ± 44 17 ± 3
Transplant, donor (n = 21) 683 ± 26 7 ± l1
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Figure 3. Relation of baseline PP interval (r = 0 .65 ; p < 0 .0001) and
systolic arterial pressure (r = -0.51 ; p = 0 .006) to heart period
variability in the recipient atria of 30 orthotopic cardiac transplant
patients .
period variability (R 2 = 0 .3 , p = 0 .03) . Systolic arterial
pressure was correlated inversely with heart period variabil-
ity as an independent variable (r = -0 .51 ; p = 0 .006) (Fig .
3) . Although insignificantly correlated (r = 0 .26 ; p = 0 .1 ) as
an independent variable, time after transplantation contrib-
uted importantly to the model, because the model R 2 was
increased from 0 .27 to 0 .3  with the addition of this variable .
Subsequent linear regression analysis of time after transplan-
tation and heart period variability in normotensive (systolic
pressure <150 mm Hg) transplant patients showed that this
factor does affect heart period variability (r = 0 .48 ; p = 0.01)
if hypertension is not present .
Arterial baroreflex slopes were measured in 22 transplant
patients . Mean baroreflex gain was 11 .7 ± 1 .0 ms/mm Hg
with a range of 2 .5 to 18.  ms/mm Hg. Least squares linear
regression analysis indicated that heart period variability
was directly related to baroreflex gain (r = 0 .62, p < 0 .001)
in these transplant patients (Fig . 4) .
Discussion
Recently, we reported (6) that baroreflex gain is normal
after cardiac transplantation . Our present study suggests
that heart period variability, used as an index of baseline
parasympathetic activity, returns toward normal after car-
diac transplantation, but often remains subnormal . We also
found normal baroreflex gains in the transplant patients . thus
y=3.8x+662
y=-0.36x+154
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Figure 4 . Relation of heart period variability to baroreflex gain in 22
orthotopic cardiac transplant patients (r = 0.62 ; p < 0 .001) . Baro-
reflex gain was determined by the RR interval response to a bolus
injection of phenylephrine .
confirming our previous observations (6) . The degree of
restoration of heart period variability was inversely related
to post-transplantation hypertension . These data suggest
that baseline parasympathetic activity can return to or
toward normal after cardiac transplantation, particularly if
hypertension does not develop .
Does heart period variability reflect cardiac vagal activity?
Heart period variability during quiet breathing is believed to
provide a semiquantitative estimate of baseline cardiac vagal
efferent nerve activity. This tenet is based on several exper-
imental observations in animals and humans . First, heart
period or rate variability is abolished or significantly reduced
by vagotomy or atropine in animals and humans ( -12) .
Second, heart period variability is directly related to cardiac
vagal efferent nerve traffic in dogs (13) . Third, changes in the
magnitude of heart period variability parallel changes in
cardiac vagal nerve traffic (13) . Several indexes of heart
period variability have been used in humans ( ,14-16) . The
index used in the present study, standard deviation of RR or
PP interval, correlates well with other indexes of heart
period variability (15,16) .
Alexopoulos et al . (17) studied the variation of I min
averages of heart rate over 24 h and found this measure to be
greatly reduced in both the recipient and the donor atria of
orthotopic cardiac transplant patients . This technique as-
sesses trends of heart rate over time that are influenced
profoundly by humoral effects . However, the applicability of
this technique to autonomic control of the heart is unknown .
Because heart period variability reflects baseline parasym-
pathetic nerve activity, our data provide new and important
insight into cardiovascular regulation in cardiac transplant
patients .
Parasympathetic activity in congestive heart failure . Con-
gestive heart failure is often associated with reduced base-
line parasympathetic activity (4), elevated baseline sympa-
thetic activity and catecholamine concentration (18,1 ), and
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al
2
E
y = 0 .12x
+ 7 . 
E
w
20
E
C
a
0
X
10
I
m
0
m
0
110
	
SMITH ET AL .
HEART PERIOD VARIABILITY IN TRANSPLANT PATIENTS
reduced baroreflex gain (1,3) . Parasympathetic activity is
inversely related to the severity of heart failure and corre-
lates directly with the prognosis of heart disease (1,20,21) .
Our mean heart period variability data clearly indicate that
the patients with heart failure had a severe reduction of
baseline parasympathetic activity (Fig . 2). These observa-
tions agree with previous reports (1,4,22) of reduced para-
sympathetic activity in congestive heart failure and coronary
artery disease .
Heart period variability tended to be slightly less in the I I
patients with heart failure who were weaned from medica-
tions than that in the 23 patients with heart failure who were
receiving medication . Although, several medications (in-
cluding nifedipine, digitalis and captopril) increase barore-
flex gain (23,24), treatment does not completely reverse the
abnormalities of heart failure . Recently, it was reported (25)
that pharmacologic and dietary treatment of patients with
heart failure improved baroreflex gain, but did not restore
normal function. Our data suggest that baseline cardiac
parasympathetic activity is subnormal in patients with heart
failure regardless of clinical treatment .
Parasympathetic activity in transplant patients . The de-
nervated donor hearts of the transplant patients demon-
strated minimal heart period variability, consistent with
previous reports (26,27) of little or no respiratory sinus
arrhythmia in transplant patients . As a group, the recipient
transplant atria clearly had greater levels of variability than
did the heart failure groups . However, it is important to note
that the distribution of the data was wider in the recipient
transplant atria than the other groups ; 16 subjects had a low
level (<30 ms) of heart period variability, whereas 10 sub-
jects had a normal level (>50 ms) (Fig . 1) . Therefore, some
transplant patients appeared to have normal parasympa-
thetic activity, whereas others were similar to patients with
heart failure . This broad variation in the transplant patients
was best explained by a model relating systolic arterial
pressure inversely and time after transplantation directly to
heart period variability . Systolic pressure contributed impor-
tantly (p = 0 .006) to the prediction of heart period variability
in the forward regression model . Time after transplantation
alone was not strongly predictive of heart period variability,
but did enhance the strength of the forward regression model
as R 2 increased from 0 .27 to 0 .3 . Furthermore, the time
after transplantation correlated with heart period variability
in normotensive transplant patients (r = 0 .48 ; p = 0.01) .
Hence, these data suggest that vagal-cardiac nerve traffic
can return toward normal after cardiac transplantation if
hypertension does not develop .
Relation of arterial baroreflex function to heart period
variability . Ellenbogen et al. (6) recently found that arterial
baroreflex gain, assessed by bolus injections of phenyleph-
rine, was normal in normotensive or mildly hypertensive
(mean arterial pressure = 104 ± 4 mm Hg) orthotopic
cardiac transplant patients (13 .0 ± 0 .  ms/mm Hg versus 2 .0
± 0.3 ms/mm Hg in patients with congestive heart failure) .
Arterial baroreflex-induced RR interval transients are pri-
marily mediated by changes of vagal efferent nerve traffic ;
hence, these findings of Ellenbogen et al . (6) suggest that
normal baroreflex-mediated parasympathetic control of the
heart is regained after cardiac transplantation. Baroreflex
gain in the normotensive transplant patients in our study
(11 .7 ± 1 .0 ms/mm Hg) was comparable with the gain
observed by Ellenbogen et al . (6) . In our patients, baroreflex
gain correlated significantly with heart period variability
(Fig. 4), suggesting that the restoration of normal baroreflex
gain and baseline parasympathetic activity are interdepen-
dent .
Mechanisms of autonomic control of cardiovascular func-
tion . Autonomic control changes in several ways in patients
after cardiac transplantation . Elevated levels of circulating
catecholamines observed in congestive heart failure return
to normal as early as 2 weeks after cardiac transplantation
(28) . The ventricle is denervated by the surgical procedure ;
hence, reflexes triggered by ventricular receptors are elimi-
nated (2,2 ,30) . These include sympathetic vasoconstrictor
responses to lower body negative pressure (2) and Bezold-
Jarisch induced bradycardia (2 ,30) . Our data suggest that
baseline parasympathetic nerve activity and arterial barore-
flex gain also return toward normal after cardiac transplan-
tation .
The mechanisms of abnormal autonomic cardiovascular
control in heart failure are not clearly understood, nor are
the mechanisms underlying the possible reversal of these
abnormalities by cardiac transplantation . Our data indicate
that, if hypertension does not develop, cardiac transplanta-
tion may be associated with a return to normal baseline
parasympathetic activity in many patients. Moreover, trans-
plant patients regain normal baroreflex-mediated parasym-
pathetic influence on the sinus node, as demonstrated by the
heart interval responses to phenylephrine injections .
We thank Helen Sheehan . RN for her help in subject recruitment and
compilation of clinical data .
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